<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00374764</url>
  </required_header>
  <id_info>
    <org_study_id>IND #58033</org_study_id>
    <nct_id>NCT00374764</nct_id>
  </id_info>
  <brief_title>Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone</brief_title>
  <official_title>Randomized Double Blind Comparison of Applied Behavioral Analysis Versus ABA and Risperidone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <brief_summary>
    <textblock>
      Hypotheses:

        1. Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only
           will demonstrate significantly better outcomes compared to an age and severity matched
           control group without ABA treatment.

        2. Preschool children with ASDs who undergo ABA in combination with risperidone will
           demonstrate significantly better outcomes compared to age and severity matched children
           who are receiving ABA alone.

        3. Young age, cognitive development and attentional abilities at baseline will be
           predictive of good socio-emotional and neuropsychological outcomes after ABA treatment.

        4. At baseline, children with ASDs will show significantly lower performances on measures
           of cognitive, neuropsychological, and socio-emotional functioning than age-matched
           typically developing controls.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2000</start_date>
  <completion_date>June 2002</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>60</enrollment>
  <condition>Autistic Disorder</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risperidone</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ABA</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of autism or severe pervasive developmental disorder (PDD) not otherwise
             specified (NOS) according to the Autism Diagnosis Interview-Revised (ADI-R)

          -  Aged 2.6 to 5.0.

        Exclusion Criteria:

          -  Fragile X or metabolic etiology of PDD symptoms

          -  Diagnosis of other central nervous system (CNS) disorders

          -  Chronic serious medical problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan Luby, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Early Emotional Development Program</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bachevalier, J. (1991). Memory loss and socio-emotional disturbances following neonatal damage of the limbic system in monkeys: An animal model for childhood autism. In C. Tamminga &amp; S. Schulz (Eds.). Advances in Psychiatry and Psychopharmacology (pp. 129-140). New York: Raven Press.</citation>
  </reference>
  <reference>
    <citation>Baron-Cohen S, Cox A, Baird G, Swettenham J, Nightingale N, Morgan K, Drew A, Charman T. Psychological markers in the detection of autism in infancy in a large population. Br J Psychiatry. 1996 Feb;168(2):158-63.</citation>
    <PMID>8837904</PMID>
  </reference>
  <reference>
    <citation>Bauman, M. &amp; Kemper, T.L. (1988). Limbic and cerebellar abnormalities: Consistent findings in infantile autism. Journal of Neuropathology and Experimental Neurology, 47, 369.</citation>
  </reference>
  <reference>
    <citation>Black JE. How a child builds its brain: some lessons from animal studies of neural plasticity. Prev Med. 1998 Mar-Apr;27(2):168-71. Review.</citation>
    <PMID>9578989</PMID>
  </reference>
  <reference>
    <citation>Butterworth, G. &amp; Jarrett, N. (1991). What minds have in common is space: Spatial mechanisms serving joint visual attention in infancy. British Journal of Developmental Psychology, 9. 55-72.</citation>
  </reference>
  <reference>
    <citation>Charman T, Swettenham J, Baron-Cohen S, Cox A, Baird G, Drew A. Infants with autism: an investigation of empathy, pretend play, joint attention, and imitation. Dev Psychol. 1997 Sep;33(5):781-9.</citation>
    <PMID>9300211</PMID>
  </reference>
  <reference>
    <citation>Chugani HT. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med. 1998 Mar-Apr;27(2):184-8. Review.</citation>
    <PMID>9578992</PMID>
  </reference>
  <reference>
    <citation>Chugani HT, Phelps ME. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science. 1986 Feb 21;231(4740):840-3.</citation>
    <PMID>3945811</PMID>
  </reference>
  <reference>
    <citation>Courchesne E, Press GA, Yeung-Courchesne R. Parietal lobe abnormalities detected with MR in patients with infantile autism. AJR Am J Roentgenol. 1993 Feb;160(2):387-93.</citation>
    <PMID>8424359</PMID>
  </reference>
  <reference>
    <citation>Damasio AR, Maurer RG. A neurological model for childhood autism. Arch Neurol. 1978 Dec;35(12):777-86.</citation>
    <PMID>718482</PMID>
  </reference>
  <reference>
    <citation>Dawson G, Adams A. Imitation and social responsiveness in autistic children. J Abnorm Child Psychol. 1984 Jun;12(2):209-25.</citation>
    <PMID>6725782</PMID>
  </reference>
  <reference>
    <citation>Dawson, G. &amp; Castelloe, P. (1995). Autism. In C.E. Walker &amp; M.C. Roberts (Eds.). Handbook of Clinical Child Psychology. New York. Plenum Press.</citation>
  </reference>
  <reference>
    <citation>Dawson G, Klinger LG, Panagiotides H, Lewy A, Castelloe P. Subgroups of autistic children based on social behavior display distinct patterns of brain activity. J Abnorm Child Psychol. 1995 Oct;23(5):569-83.</citation>
    <PMID>8568080</PMID>
  </reference>
  <reference>
    <citation>Dawson, G. &amp; Lewy, A. (1989). Reciprocal subcortical-cortical influences in autism: The role of attentional mechanisms. In G. Dawons (Ed.), Autism: Nature, Diagnosis, and Treatment (pp. 144-173). New York: Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Dawson G, Meltzoff AN, Osterling J, Rinaldi J. Neuropsychological correlates of early symptoms of autism. Child Dev. 1998 Oct;69(5):1276-85.</citation>
    <PMID>9839415</PMID>
  </reference>
  <reference>
    <citation>Dawson, G., Warrenburg, S. &amp; Fuller, P. (1996. Early intervention in autism. In M.J. Guralnick (Ed.), The Effectiveness of Early Intervention. Baltimore, MD: Paul Brookes Publishing Co.</citation>
  </reference>
  <reference>
    <citation>Dawson G, Warrenburg S, Fuller P. Cerebral lateralization in individuals diagnosed as autistic in early childhood. Brain Lang. 1982 Mar;15(2):353-68.</citation>
    <PMID>7074350</PMID>
  </reference>
  <reference>
    <citation>Diamond, A. &amp; Goldman-Rakic, P.S. (1985). Evidence for involvement of prefrontal cortex in cognitive changes during the first year of life: comparison of human infants to rhesus monkeys on a detour task with transparent barrier. Society for Neurosciences Abstracts (Part II), 11, 832.</citation>
  </reference>
  <reference>
    <citation>Diamond, A. &amp; Goldman-Rakic, P.S. (1986). Comparative development in human infants and infant rhesus monkeys on cognitive functions that depend on the prefrontal cortex. Society of Neurosciences Abstracts, 12, 742.</citation>
  </reference>
  <reference>
    <citation>Fenske, E.D., Zalenski, S., Krantz, P.J., &amp; McClannahan, L.E. (1985). Age at intervention and treatment outcome for autistic children in a comprehensive intervention program. Analysis and Intervention in Developmental Disabilities, 5, 49-58.</citation>
  </reference>
  <reference>
    <citation>George MS, Costa DC, Kouris K, Ring HA, Ell PJ. Cerebral blood flow abnormalities in adults with infantile autism. J Nerv Ment Dis. 1992 Jul;180(7):413-7.</citation>
    <PMID>1624921</PMID>
  </reference>
  <reference>
    <citation>Gilliam, J.E. (1995). Gilliam Autism Rating Scale, Austin, TX: PRO-ED, Inc.</citation>
  </reference>
  <reference>
    <citation>Goldman-Rakic, P.S. (1987). Circuitry of primate prefrontal cortex and regulation of behavior by representational knowledge. In F. Plum &amp; V. Mountcastle (Eds.), Handbook of Physiology, 5, 373-417.</citation>
  </reference>
  <reference>
    <citation>Goldsmith, H.H. &amp; Rothbart, M.K. (1996). The Laboratory Temperament Assessment Battery, Locomotor Version 3.0. Madison, Wisconsin: Department of psychology, University of Wisconsin.</citation>
  </reference>
  <reference>
    <citation>Elyse, P., Luby, J., Abbacchi, A., &amp; Constantino, J.N. Quantitative Assessment of Autistic Symptomatology in Preshoolers. In Press.</citation>
  </reference>
  <verification_date>June 2002</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2006</study_first_submitted>
  <study_first_submitted_qc>September 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2006</study_first_posted>
  <last_update_submitted>February 15, 2007</last_update_submitted>
  <last_update_submitted_qc>February 15, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2007</last_update_posted>
  <keyword>Autism, Applied Behavioral Analysis, Risperidone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Risperidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

